NC-based Biolex names Kurt Graves executive chair
Biolex Therapeutics has named industry veteran Kurt Graves as executive chair as the company prepares to move into Phase 3 trials of Locteron to treat hepatitis C.... [more]
Biolex Therapeutics has named industry veteran Kurt Graves as executive chair as the company prepares to move into Phase 3 trials of Locteron to treat hepatitis C.... [more]
